Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	395.03	128.03	393.64	595.08	7.23	-
Short-Term Investments	123.42	128.52	-	-	-	-
Cash & Short-Term Investments	518.45	256.55	393.64	595.08	7.23	-
Cash Growth	84.28%	-34.83%	-33.85%	8134.15%	-	-
Other Receivables	-	39.15	26.72	16.81	2.93	-
Receivables	-	39.15	26.72	16.81	2.93	-
Prepaid Expenses	-	1.65	2.79	4.66	0.01	-
Other Current Assets	-	17.74	14.59	12.22	1	-
Total Current Assets	518.45	315.09	437.75	628.77	11.17	-
Property, Plant & Equipment	-	12.95	1.17	0.16	-	-
Long-Term Deferred Tax Assets	-	29.65	3.51	-	-	-
Other Long-Term Assets	91.27	2.55	1.88	0.7	0.55	-
Total Assets	609.72	360.25	444.31	629.64	11.72	-
Accounts Payable	-	11.82	13.84	8.07	1.03	-
Accrued Expenses	-	26.62	22.23	15.7	1.04	-
Short-Term Debt	-	-	-	-	5.63	-
Current Portion of Leases	-	0.51	-	-	-	-
Current Income Taxes Payable	-	0.11	1.58	0.77	-	-
Other Current Liabilities	-	0.33	0.69	0.1	0.92	-
Total Current Liabilities	-	39.39	38.34	24.64	8.62	-
Long-Term Debt	75.7	75.7	69.8	75.7	-	-
Long-Term Leases	-	8.89	-	-	-	-
Other Long-Term Liabilities	34.88	0.03	-	37.74	-	-
Total Liabilities	110.58	124	108.14	138.08	8.62	-
Common Stock	499.14	0.27	0.27	0.25	25.55	-
Additional Paid-In Capital	-	987.42	939.26	876.27	0.83	-
Retained Earnings	-	-752.95	-601.86	-385.65	-23.85	-
Comprehensive Income & Other	-	1.49	-1.5	0.69	0.57	-
Shareholders' Equity	499.14	236.24	336.17	491.55	3.1	-
Total Liabilities & Equity	609.72	360.25	444.31	629.64	11.72	-
Total Debt	75.7	85.09	69.8	75.7	5.63	-
Net Cash (Debt)	442.75	171.46	323.84	519.38	1.6	-
Net Cash Growth	123.79%	-47.06%	-37.65%	32361.38%	-	-
Net Cash Per Share	4.18	1.78	3.47	6.91	0.11	-
Filing Date Shares Outstanding	116.25	100.31	94.96	94.02	15	-
Total Common Shares Outstanding	116.25	98.77	94.84	89.99	15	-
Working Capital	518.45	275.71	399.41	604.14	2.55	-
Book Value Per Share	4.29	2.39	3.54	5.46	0.21	-
Tangible Book Value	499.14	236.24	336.17	491.55	3.1	-
Tangible Book Value Per Share	4.29	2.39	3.54	5.46	0.21	-
Machinery	-	1.5	0.44	0.2	-	-
Construction In Progress	-	-	0.89	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.